TrialJournal of clinical immunology2010
Immunoglobulin dosage and switch from intravenous to subcutaneous immunoglobulin replacement therapy in patients with primary hypogammaglobulinemia: decreasing dosage does not alter serum IgG levels.
Sylvain Thépot et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this paperpooled ittrialcites it